TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2018

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G).

Yuji Miura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.